Veterinary & Biosecurity
Mak, Alfasan Sign Anti-Tick Vaccine Production MoU
Makerere University on Friday 19th March, 2021 signed a Memorandum of Understanding (MoU) with Alfasan Uganda Limited to facilitate production of test batches of the Anti-Tick Vaccine developed by the College of Veterinary Medicine, Animal Resources and Biosecurity (CoVAB). The MoU was signed on behalf of Makerere University by the Vice Chancellor, Prof. Barnabas Nawangwe and on behalf of Alfasan by the Managing Director Dr. Stephen Birungi. The Principal CoVAB-Prof. John David Kabasa, Anti-Tick Vaccine Initiative Principal Investigator (PI)-Dr. Margaret Saimo-Kahwa and Acting (Ag.) Manager Intellectual Property Management Office (IPMO)-Canon Goddy Muhumuza signed as witnesses.
The Anti-Tick Vaccine Initiative is hosted under the Centre for Biosecurity and Global Health, CoVAB. According to the Prof. Kabasa, the Centre was one of the milestones endorsed by the University when the then faculty to college transition was proposed. “I am happy to report that the Centre is being vigorously supported by the Government to undertake activities of vaccine development together with other scientists.”
He thanked the Vice Chancellor always taking keen interest in the multidisciplinary programmes undertaken by the college with a view improving the livelihoods of both small and large scale livestock farmers. He equally lauded the CoVAB scientists for their efforts to develop the Anti-Tick Vaccine and stakeholders such as the Africa Institute for Strategic Animal Resource Services and Development (AFRISA), Centre of Tropical Medicine and the Ruth Keesling Wildlife Health, Research and Outreach Centre (RK_WHERE) for their support.
Unveiling the research challenge and solution, the PI Dr. Margaret Saimo-Kahwa noted that ticks as vectors for diseases like East Coast Fever are an economic threat to farmers with herds of exotic breeds, their crosses and increasingly, local breeds raised in a tick-free environment. Furthermore, common tick species in Uganda have developed resistance to acaricides used in spraying as a method of their control. This resistance is further exacerbated by acaricide contamination of the environment, leading to residues in animal products like milk and meat, which have implications on human health.
“Therefore, alternative methods like anti-tick vaccines that reduce the use of acaricides are urgently needed to protect the livestock sector that plays a role in poverty reduction and contributes at least 3.2% to Uganda’s GDP, which is equivalent to about 1 Trillion Uganda Shillings” said Dr. Saimo-Kahwa.
The efficacy of any innovation is measured by how well it has worked elsewhere. The Anti-Tick Vaccine Initiative therefore sought inspiration from Australia, where the first anti-tick vaccine was developed in the 1980s as well as Cuba where the vaccines have been used successfully for over 20 years. Gleaning further from Brazil, the team used biotechnology approaches to develop antigens that can target the ticks in Uganda.
“Testing of these molecules under laboratory conditions with funding from the Government of Uganda has been done” remarked the Principal Investigator before adding, “The next step is to test these molecules in clinical trials. However, the molecules should be manufactured under Good Manufacturing Practice (GMP) and not under laboratory conditions.”
Dr. Saimo-Kahwa at this point thanked the President, H.E. Yoweri Kaguta Museveni, whose advice led the research team to the GMP-certified Alfasan Uganda Limited. “These negotiations have been fruitful, leading to the drafting of a memorandum of understanding for production of test batches of the potential vaccine, with funding from Government of Uganda.”
Dr. Stephen Birungi a Makerere University alumnus from CoVAB was all praises for his alma mater and commended Prof. Barnabas Nawangwe for ushering in era of innovation in the short time he has served as Vice Chancellor. “If we are seeing a threat to the livestock industry, we need to act now to save the 20-30% of Uganda’s 15million head of cattle that we lose annually due to tick-borne diseases.”
He reassured all present that Alfasan, a private company certified for the production of veterinary biologicals, was fully committed to improving the livelihood of Ugandan livestock farmers by partnering with the Government of Uganda and institutions such as Makerere University.
“Alfasan as a factory that was born out of partnership between Uganda and Holland is ready to give the facilities that will convert this beautiful innovation from Makerere; once again proving that Makerere is not just a theoretical teaching institution but is ready to bring out those products that can change lives in our country” affirmed Dr. Birungi.
He thanked Makerere University for recognizing the need to produce homegrown vaccines, noting that imported batches tend become less efficacious after multiple applications due to varying protein compositions of the ticks in countries where the remedies originate and Uganda.
“It is therefore important that Government doubles the effort to support CoVAB and Makerere University so that we don’t only stop at this solution but go out and solve even bigger problems using research that has been proven such as this anti-tick vaccine” Dr. Birungi added.
Makerere University is home to a number of innovations, whose number keeps growing thanks to generous funding from the Government and other partners. In recognition of the need to translate these innovations into commercially viable products, the University introduced an Intellectual Property Management Office and appointed Canon Goddy Muhumuza as Ag. Manager. Guiding the MoU signing ceremony, Canon Muhumuza, who also doubles as Principal Legal Officer, made specific mention of the clause on “Ownership” clarifying that Makerere University shall own the patent of the vaccine.
“A new dawn is setting on Makerere University. Makerere University is becoming a truly international research university,” commenced the Vice Chancellor as he made closing remarks following the brief MoU signing and exchange ceremony.
He thanked Dr. Saimo-Kahwa for her great work and mentorship as shown by the constitution of her team, mainly made up of young people. The team is made up of Scientists; Dr. Olaho Mukhani William, Dr. Kokas Ikwap, Dr. Mukiibi Herbert, Dr. Ochwo Sylvester, Dr. Musadha Zachary and Mr. Peregrine Sebulime.
In order to study the life and breeding cycles of ticks, the Initiative included a specialist (Acarologist), Mr. Charles Ssekitto. Technicians who form part of the team include; Mr. Geoffrey Ssentamu, Mr. Nalumenya David, Ms. Namubiru Sarah and Mr. Abubaker Musoba. Mr. Gerald Brooks Musinguzi is in charge of Communication while Ms. Kaudha Rose is the Administrator.
The Vice Chancellor noted that the capacity to develop vaccines was evidence of attaining to the highest levels of research capacity and expressed great pride to learn that the team was completely Ugandan. He thanked the Government of Uganda for the heavily investing in research at Makerere University and reminded staff of their obligation to give back to the taxpayers by providing good accountability.
“I must thank the leadership of the college for the great work they are doing. Professor Kabasa is passionate about Makerere and Uganda and what we should be doing to develop our country” remarked Prof. Nawangwe.
Results from the trials conducted so far showed that the overall efficacy of the vaccine candidate proteins was 86% for R appendiculatas (the brown ear tick) that transmits East Coast Fever (ECF) and 53% for R decoloratus that transmits Babesiosis. “If this vaccine can reduce the burden of tick borne diseases, we will have through one single innovation made a huge contribution to solving one of Uganda’s biggest problems.”
Prof. Nawangwe thanked Alfasan Uganda Limited for being pioneers in implementing academia-private sector collaboration. “As we come up with more innovations and move towards being a research-led University, it is inevitable that we have to work with the private sector, and I thank Managing Director for this gesture… you are a good alumnus.”
This MoU marks the beginning of a long and mutually beneficial partnership between academia and the private sector. The Anti-Tick Vaccine Initiative intends to expand the immunization to include more animals and carry out a clinical trial to determine the appropriate dosage and schedule. Furthermore, the Anti-Tick Vaccine candidate proteins offer more opportunities to include other candidate vaccine proteins of other cattle diseases into the combination.
The event was moderated by the Principal Public Relations Officer, Ms. Ritah Namisango and the Communication Officer CoVAB, Mr. Gerald Brooks Musinguzi.
Article by Public Relations Office
Veterinary & Biosecurity
Uganda Advances Bacteriophage Research in Fight against Antimicrobial Resistance
Makerere University convened a symposium to explore bacteriophage applications in combating antimicrobial resistance (AMR) and addressing health, agricultural, and environmental challenges. Organized by The Alliance for Phage Research and Development Uganda Ltd (PhageTeam Uganda), the event brought together researchers from Makerere University, Kyambogo University, Kampala International University, and Ian Clarke International University, and other players, highlighting a collaborative approach to tackling global and local issues.
Day two of the symposium saw researchers and policy makers together with partners from the UK and USA hold a discourse on the best way forward in the promotion of bacteriophage research and production in the country to support efforts against anti-microbial resistance.
Speaking at the event held at Hilton Garden Inn, Dr. Jesca Nakavuma, the lead phage researcher from the College of Veterinary Medicine, Animal Resources and Biosecurity (CoVAB), Makerere University, stressed the urgent need for alternative antimicrobial agents due to the rise in drug resistance and limited discovery of new antibiotics. Bacteriophages, natural viruses that target bacteria, she said, were identified as a promising solution to revolutionize disease control, treatment, and food security. She said research in this area was key because humankind was at risk of the impending calamity of life-threatening treatment failure.
Prof. Robert Wamala, Makerere University‘s Director for Research, Innovations, and Partnerships, who spoke on behalf of the Vice Chancellor, Prof. Barnabas Nawangwe, underscored the importance of building local capacity in phage research. He noted that such efforts could enhance Uganda’s resilience against AMR and yield homegrown solutions for human, animal, and crop health.
As the world grapples with the growing threat of antimicrobial resistance (AMR), bacteriophage research offers a promising alternative. Phages, which are natural enemies of bacteria, have the potential to revolutionize the approach to treatment, disease control, and food security, he noted. He said building local expertise in phage application can enhance Uganda’s resilience against AMR and produce sustainable homegrown solutions to health and environmental challenges.
Prof. Robert Wamala said Makerere University was committed to supporting cutting-edge research and innovation that addresses national and global challenges in line with the university’s role in knowledge generation, technology advancement, and policy influence. The importance of regulatory institutions, he said, cannot be overemphasized in this endeavor, since they enforce compliance, uphold ethical standards, and foster an enabling environment for impactful research and innovation. He said the engagement presented an opportunity to strengthen collaboration between researchers, institutions, and regulatory bodies to ensure that the outcomes are scientifically sound and are aligned to the national development priorities and global best practices.
Dr. Claire M. Mugasa, the Dean of the School of Biosecurity, Biotechnical and Laboratory Sciences (SBLS), CoVAB reiterated the fact that antimicrobial resistance was on the rise in Uganda and Africa, more than elsewhere in the world. She said it was time now that efforts be intensified in looking for sustainable options to curb the dangerous trends. She said this cuts across the human and the animals. She said it was an opportune time for players to come together to find ways of getting the required alternative. She said by coming together, the different ideas developed individually would in a concerted effort, pulling resources together for a way forward.
During the discourse, several subjects were addressed, including an introduction to antimicrobial resistance, phage biology, phage application, and lessons learnt from the establishment of a phage research centre in the UK, which was presented by Prof. Martha Clokie from the University of Leicester. This initiative reflects a commitment to fostering innovation, collaboration, and regulatory compliance, positioning Uganda as a leader in sustainable solutions for global challenges.
The symposium was sponsored by Global AMR Innovation Fund (GAMRIF), through a grant to the UK Medicines and Healthcare products Regulatory Agency (MHRA) in partnership with Phages for Global Health.
Veterinary & Biosecurity
First Symposium on Bacteriophage Research & Applications in Uganda Highlights Remarkable Milestones & Future Prospects
Bacteriophage research and its applications were the focal point of the 1st Symposium on Bacteriophage Research and Applications, convened by Makerere University‘s College of Veterinary Medicine, Animal Resources and Biosecurity (CoVAB) on Thursday, March 27, 2025. This landmark event showcased Uganda’s strides in harnessing bacteriophages as innovative solutions to antimicrobial resistance (AMR) and other pressing health and agricultural challenges.
Key speakers included Dr. Jesca Nakavuma, CoVAB (Makerere University), who showcased Uganda’s pioneering phage research initiatives and vision. Tobi Elaine Nagel, the President of Phages for Global Health (USA), discussed the global significance of phage research. Prof. Martha Clokie, from the University of Leicester’s Centre for Phage Research (UK), shared insights into the latest advancements in phage therapy. Dr. Robert Blasdel, representing VASALE (Belgium), presented innovative solutions using bacteriophages. Ms. Abigail Riggs, from the Foreign, Commonwealth and Development Office (UK), emphasized international partnerships and policy development.
Speaking at the event, Prof. Edward Wamala, Makerere University’s Director of Research, Innovation and Partnerships, who represented the Vice Chancellor Prof. Barnabas Nawangwe at the event, highlighted the critical role of bacteriophage research in addressing the global threat of antimicrobial resistance (AMR). He explained how the misuse and overuse of antibiotics in human health, agriculture, and aquaculture have accelerated the emergence of drug-resistant bacterial strains, rendering standard treatments ineffective. Citing statistics from the World Health Organization, he pointed out that AMR claims over 1.3 million lives annually, a number expected to rise without urgent action. He lamented the stagnation of new antibiotic development due to high research costs and rapid bacterial resistance, making bacteriophage therapy a powerful and promising alternative.
Prof. Wamala expressed Makerere University’s commitment to advancing research that addresses critical societal challenges, aligning with its mission of generating transformative knowledge and fostering sustainable development. He emphasized Uganda’s potential to lead in bacteriophage research, driven by multi-disciplinary partnerships and capacity building. He also highlighted ongoing studies into aquaculture-specific bacteriophages at CoVAB as an example of how phage technology can revolutionize sectors like agriculture while addressing AMR. Through such efforts, the university aims to position Uganda as a global leader in innovative solutions to combat antimicrobial resistance and enhance public health.
Dr. Jesca Nakavuma, widely regarded as the mother of phages in Uganda, delivered a compelling presentation at the Symposium, where she detailed the impressive progress of phage research in Uganda since its inception in 2017. She highlighted Makerere University’s pioneering efforts, starting with a cohort of five undergraduate students, which have since expanded into groundbreaking research addressing challenges in agriculture, clinical health, food safety, and environmental safety. Key achievements include advancements in E. coli and Salmonella detection, tackling avian colibacillosis, and innovations in decontamination methods, underscoring the transformative potential of phage technology in combating antimicrobial resistance and enhancing public health.
The symposium honored collaborative efforts, including the establishment and accomplishments of Phage Team Uganda, which developed a repository of 125 characterized phage isolates and trained over 20 PhDs, MScs, and BSc students. Partnerships with international organizations such as IDRC InnoVet AMR and AU Safe Fish have significantly contributed to advancements in antimicrobial resistance and aquaculture.
Despite these achievements, Dr. Nakavuma noted challenges such as insufficient facilities for large-scale phage production, regulatory limitations, and financial constraints. She affirmed that despite the challenges, the team remained ambitious, envisioning the creation of a fully equipped Phage Research and Development Center, the commercialization of phage products, and the establishment of policy frameworks to support the use of phages in Uganda.
The Deputy Principal of CoVAB, Prof. James Acai Okwee, warmly welcomed the partners to the conference and acknowledged their invaluable contributions to the college’s research efforts. He emphasized the importance of collaboration in driving innovation and achieving impactful results, highlighting the pivotal role that partnerships play in fostering academic and scientific growth. Prof. Okwee’s remarks set an encouraging tone for the conference, reinforcing the college’s commitment to advancing research initiatives and creating opportunities for shared learning and development.
The event that attracted the participation of various stakeholders including academia, civil society, and policy makers, concluded with acknowledgments of the efforts of Phage Team Uganda, collaborators, and funders, setting the stage for an exciting future in Uganda’s journey to combat antimicrobial resistance and ensure food and environmental safety.
The Makerere University Biomedical Laboratory Technology Students Association (MUBLISA) recently organized a transformative mentorship meeting at the College of Veterinary Medicine, Animal Resources, and Biosecurity (CoVAB) at Makerere University, inspiring students to excel in biomedical laboratory technology. The mentorship session aimed to bridge the gap between academic knowledge and real-world application while promoting diversity, inclusion, and professional development.
Two accomplished alumni were present at the event and they shared invaluable insights into thriving in the professional landscape beyond academic lectures. Their stories resonated with attendees, providing practical advice and motivation to navigate the challenges of building successful careers. It was also attended by the Dean, of the School of Biosecurity, Biotechnology and Laboratory Sciences (SBLS), Dr. Claire M. Mugasa.
Dr. Kiyemba Stephen Kaggwa, the distinguished director of Ebenezer Laboratories, delivered an uplifting keynote address that left a lasting impression on students and professionals alike. Known for his groundbreaking contributions to biomedical laboratory technology, Dr. Kaggwa encouraged aspiring professionals to explore their field’s untapped potential and underscored the transformative role of mentorship in fostering personal and professional growth.
Dr. Kaggwa, who leads Ebenezer Laboratories, an institution celebrated for its dedication to accurate diagnostics and advancing medical science in the region as a prominent clinical laboratory based in Kampala, further demonstrated his commitment to healthcare innovation and patient-centered care. The inspiring event served as a powerful reminder of the importance of leadership, mentorship, and innovation in shaping the next generation of professionals. It left students motivated to not only succeed but also to make a meaningful impact in their chosen fields.
The other speaker, Ms. Eunice Ainomugisha, the Vice Chair of the Allied Health Professionals Council where she represents the medical laboratory reiterated the value of building meaningful relationships and staying organized to seize opportunities. Ainomugisha who illustrated her points by using her own experience as a struggling young girl to seize the available opportunities in the field, encourages the students to dream big and seek out the best for themselves despite the circumstances.
Dr. Gabriel Tumwine, representing the head of the Biomedical Laboratory Technology Department, Dr. Kato Drago highlighted the need for mentorship alongside academic training. He commended MUBLISA for taking the lead in empowering students to develop connections and skills essential for their careers. Students were inspired by the event’s message of perseverance, hard work, and the “power of right connections.” This pioneering mentorship program set the stage for many more initiatives aimed at equipping biomedical laboratory technology students with tools for success in academia, research, and industry.
The mentorship meeting not only celebrated the achievements of the department but also served as a powerful reminder of the impact Makerere University‘s graduates continue to make in advancing health and scientific research.
-
General6 days agoPre-Entry Examinations for Admission to Bachelor of Laws 2025/26
-
General1 day agoRE-Advert: Position of First Deputy Vice Chancellor
-
General1 week agoSsentamu Churchill Sworn-in as 91st Makerere Guild President
-
General1 day agoRe-Advert: Position of Second Deputy Vice Chancellor
-
General5 days agoOffice of the Academic Registrar Lauded for Groundbreaking Achievements In Digitalization